Medtronic (MDT) Tops Q3 EPS by 3c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Raymond James Reiterates Market Perform Rating on Medtronic, Inc. (MDT)
February 18, 2025 8:13 AM ESTRaymond James analyst Jayson Bedford reiterated a Market Perform rating on Medtronic, Inc. (NYSE: MDT).
The analyst comments "F3Q results were mixed, as revenue missed and adj. EPS beat. The primary revenue variance (vs. RJe/consensus) was in Surgical, which... More

